Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  ALK-Abello A/S    ALK B   DK0060027142

ALK-ABELLO A/S (ALK B)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

ALK-Abello A/S : Grant of share options and conditional shares to members of the Board of Management and key employees

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 10:19am CEST

Copenhagen, 2012-05-11 08:55 CEST (GLOBE NEWSWIRE) --

Share option programme
According to the guidelines for incentive pay adopted at the Company's annual general meeting on 27 March 2012, the Board of Directors has passed a resolution to grant a total of 101,000 share options, comprising 40,250 options to the members of the Board of Management and 60,750 options to a group of key employees.

The options can be exercised during the period from 1 May 2015 to 1 May 2019 during the four-week trading windows following the release of annual and interim reports. If the option holders have not exercised their options within the period specified, the options will lapse without any compensation to the holders.

The exercise price of the options has been set at DKK 399 each, corresponding to an average of the closing prices of the company's shares on the NASDAQ OMX Copen­hagen A/S during the period 2 - 9 May 2012 (both days included). To this should be added annual interest at the rate of 2.5%, which will be added the first time on 1 May 2013. The exercise price of the options will be adjusted on payment of dividend, to the effect that DKK 1 of dividend per share results in a reduction of the exercise price by DKK 1.

The market value of the adopted option plan of 101,000 options is approximately DKK 6 million applying the Black & Scholes model for valuation of options. The determination of the value is based on an assumed exercise price of DKK 440, an annual dividend distribution of DKK 5 per share, a volatility rate of 22% p.a. and a risk-free interest rate of 1.49% p.a.

Conditional share programme
The Board of Directors has passed a resolution to grant conditional shares in accordance with the guidelines for incentive pay adopted at the Company's annual general meeting. The scheme comprises a total of 15,300 conditional shares, including 6,100 shares to the members of the Board of Management and 9,200 shares to a group of key employees. The market value of the conditional shares is approximately DKK 6 million, calculated on the basis of an average of the closing prices of the company's shares on the NASDAQ OMX Copenhagen A/S during the period 2 - 9 May 2012 (both days included).

Conditional shares will be available in May 2015, three years following the date of grant, provided that ALK achieves the financial targets for vesting and that the employment relationship with the ALK Group has not been terminated by the Company on objective grounds or terminated during the three-year period from the date of grant in 2012.

Under the international financial reporting standards (IFRS), the incentive plans will be recognised in the income statement in the respective functional areas over the vesting period.

The grant of share options and conditional shares does not change the company's financial forecast.

No share options or conditional shares have been granted to members of the Board of Directors.



ALK-Abelló A/S

Steen Riisgaard
Chairman

For further information please contact:
Steen Riisgaard, Chairman of the Board of Directors, tel +45 4446 0000



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALK-ABELLO A/S
05/10In Europe, Mylan's rivals try to plug EpiPen shortages
RE
05/04ALK ABELLO A/S : Three-month interim report (Q1) 2018
AQ
05/01ALK-ABELLO A/S : quaterly earnings release
05/01ALK ABELLO A/S : Release date of three-month interim report (Q1) 2018 and audio ..
AQ
04/18ALK ABELLO A/S : partner for Japan, Torii, secures pricing for new Japanese ceda..
AQ
04/11ALK ABELLO A/S : announces allergy diagnostic partnership with Rellergen in Chin..
AQ
03/20ALK ABELLO A/S : Report on transactions with ALK-Abelló A/S B-shares and associa..
AQ
03/20ALK ABELLO A/S : Grant of share options and performance shares to members of the..
AQ
03/16ALK ABELLO A/S : Articles of Association
AQ
02/16ALK ABELLO A/S : partner, Torii, gains paediatric approval for the house dust mi..
PU
More news
News from SeekingAlpha
2017Alk Abello AS (AKBLF) - Investor Presentation - Slideshow 
2017Pricing set in France for ALK's dust-mite allergy pill Acarizax 
2017Alk Abello AS ADR 2017 Q3 - Results - Earnings Call Slides 
2017ALK accelerates commercial launch of dust mite tablet in North America to Q4;.. 
2017ALK-ABELLO AS B SHS 2017 Q2 - Results - Earnings Call Slides 
Financials ( DKK)
Sales 2018 2 765 M
EBIT 2018 -172 M
Net income 2018 -232 M
Debt 2018 561 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 3,93x
EV / Sales 2019 3,71x
Capitalization 10 311 M
Chart ALK-ABELLO A/S
Duration : Period :
ALK-Abello A/S Technical Analysis Chart | ALK B | DK0060027142 | 4-Traders
Technical analysis trends ALK-ABELLO A/S
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 916  DKK
Spread / Average Target -10%
EPS Revisions
Managers
NameTitle
Carsten Hellmann President & Chief Executive Officer
Steen Riisgaard Chairman
Soren Jelert Chief Financial Officer & Executive Vice President
Henrik Hugo Jacobi Executive Vice President-Research & Development
Anders Gersel Pedersen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALK-ABELLO A/S37.57%1 613
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970